Compared side by side
Epitalon vs DSIP: how they differ
The short answer
Both are linked to sleep, by different routes: epitalon is a tetrapeptide modeled on a pineal gland extract that, in animals, helps regulate melatonin, and DSIP is a neuropeptide named for boosting deep-sleep (delta) brain waves in rabbits. Small human trials found weak or no sleep benefit from DSIP, and epitalon’s research is almost all by its developers. Both run in short cycles: DSIP for 5–10 days, epitalon for 10–20 days 2–3 times a year.
Side by side
| Compared | Epitalon | DSIP |
|---|---|---|
| Category | Longevity | Longevity |
| Also known as | Epithalamin, Tetrapeptide AEDg, Epithalon | Delta Sleep-Inducing Peptide, Delta sleep peptide |
| What it is | A synthetic peptide modeled on a pineal gland extract from Russian longevity research. | A neuropeptide named for deepening sleep: it boosted deep-sleep (delta) brain waves in rabbits, though small human trials found weak or no sleep benefit and no effect on cortisol. |
| How it works | Synthetic tetrapeptide designed to match the amino-acid make-up of the pineal gland extract Epithalamin. In cell studies it activates telomerase and lengthens telomeres; in rodent studies it regulates melatonin secretion and has antioxidant effects. Studied mainly in Russian longevity research by its developers. | Neuropeptide named for boosting deep-sleep (delta) brain waves in rabbits; human sleep studies found small or no effects. Early lab and animal work suggested it dampens stress hormones, but a human study found no effect on ACTH or cortisol. Antioxidant and mild pain-relieving effects come from rodent studies. |
| Commonly reported | Deeper sleep and more vivid dreams during a cycle, with little else to feel. The research is almost all by its developers, and no independent controlled human trial exists. | Mixed, with some describing deeper sleep and vivid dreams while many notice nothing, and morning grogginess at higher doses. Used in short 5-10 day cycles for disrupted sleep or high-stress periods. |
| Studied range | Research range: 5–10 mg. Studied in research — not a recommendation. | Research range: 200–400 mcg. Studied in research — not a recommendation. |
| How often | Daily for 10–20 day cycles | Nightly or as needed 30-60 min before sleep. Short cycles of 5-10 days. |
| Half-life | Short (peptide) | Short (rapidly degraded in blood) |
| Route | SubQ injection, IM injection | SubQ injection |
| Typical run | 10–20 day intensive cycle, 2–3 times per year. This is the most consistent community approach. | Community protocols use 5-10 day cycles with equal time off, typically for disrupted sleep or high-stress periods. |
| Evidence | Moderate: animal studies + some human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Injection site reaction, mild headache, vivid dreams | Mild headache, vivid dreams, morning grogginess at higher doses |
- Category
- EpitalonLongevity
- DSIPLongevity
- Also known as
- EpitalonEpithalamin, Tetrapeptide AEDg, Epithalon
- DSIPDelta Sleep-Inducing Peptide, Delta sleep peptide
- What it is
- EpitalonA synthetic peptide modeled on a pineal gland extract from Russian longevity research.
- DSIPA neuropeptide named for deepening sleep: it boosted deep-sleep (delta) brain waves in rabbits, though small human trials found weak or no sleep benefit and no effect on cortisol.
- How it works
- EpitalonSynthetic tetrapeptide designed to match the amino-acid make-up of the pineal gland extract Epithalamin. In cell studies it activates telomerase and lengthens telomeres; in rodent studies it regulates melatonin secretion and has antioxidant effects. Studied mainly in Russian longevity research by its developers.
- DSIPNeuropeptide named for boosting deep-sleep (delta) brain waves in rabbits; human sleep studies found small or no effects. Early lab and animal work suggested it dampens stress hormones, but a human study found no effect on ACTH or cortisol. Antioxidant and mild pain-relieving effects come from rodent studies.
- Commonly reported
- EpitalonDeeper sleep and more vivid dreams during a cycle, with little else to feel. The research is almost all by its developers, and no independent controlled human trial exists.
- DSIPMixed, with some describing deeper sleep and vivid dreams while many notice nothing, and morning grogginess at higher doses. Used in short 5-10 day cycles for disrupted sleep or high-stress periods.
- Studied range
- EpitalonResearch range: 5–10 mg. Studied in research — not a recommendation.
- DSIPResearch range: 200–400 mcg. Studied in research — not a recommendation.
- How often
- EpitalonDaily for 10–20 day cycles
- DSIPNightly or as needed 30-60 min before sleep. Short cycles of 5-10 days.
- Half-life
- EpitalonShort (peptide)
- DSIPShort (rapidly degraded in blood)
- Route
- EpitalonSubQ injection, IM injection
- DSIPSubQ injection
- Typical run
- Epitalon10–20 day intensive cycle, 2–3 times per year. This is the most consistent community approach.
- DSIPCommunity protocols use 5-10 day cycles with equal time off, typically for disrupted sleep or high-stress periods.
- Evidence
- EpitalonModerate: animal studies + some human data
- DSIPEmerging: primarily preclinical / limited human data
- Common side effects
- EpitalonInjection site reaction, mild headache, vivid dreams
- DSIPMild headache, vivid dreams, morning grogginess at higher doses
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Epitalon
- Day 1–5 Short, intense cycles
- Day 5–20 Deep in the cycle
DSIP
- Day 1–3 Deeper sleep, for some
- Day 3–10 Mid-cycle: judge it by your sleep
Together or one or the other
Epitalon and DSIP are a common stack: DSIP lists epitalon among its common stacks.
Questions people ask
How long do epitalon and DSIP last?
The half-life of epitalon is short (peptide). The half-life of DSIP is short (rapidly degraded in blood).
How often are epitalon and DSIP taken?
Epitalon: daily for 10–20 day cycles. Routes: SubQ injection, IM injection. DSIP: nightly or as needed 30-60 min before sleep. Short cycles of 5-10 days. Route: SubQ injection.
How are epitalon and DSIP dosed in research?
The research range for epitalon is 5–10 mg. The research range for DSIP is 200–400 mcg. Studied in research — not a recommendation.
What are the common side effects of epitalon and DSIP?
For epitalon, the library lists: injection site reaction, mild headache, vivid dreams. For DSIP: mild headache, vivid dreams, morning grogginess at higher doses.
Are epitalon and DSIP taken together?
Epitalon and DSIP are a common stack: DSIP lists epitalon among its common stacks.